Netherton S Syndrome clinical trials

Explore recruiting netherton s syndrome clinical trials.

Also recruiting in Europe

Netherton S Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A PHASE 1/1B STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND IMMUNOGENICITY OF SINGLE AND MULTIPLE ASCENDING DOSES OF BCX17725 IN HEALTHY PARTICIPANTS AND MULTIPLE DOSES OF BCX17725 IN PARTICIPANTS WITH NETHERTON SYNDROME

France, Netherlands, Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Netherton S Syndrome trials by city

Netherton S Syndrome in Toronto Netherton S Syndrome in Vancouver Netherton S Syndrome in Montreal Netherton S Syndrome in Calgary Netherton S Syndrome in Edmonton Netherton S Syndrome in Ottawa Netherton S Syndrome in Winnipeg Netherton S Syndrome in Quebec City Netherton S Syndrome in Hamilton Netherton S Syndrome in Kitchener Netherton S Syndrome in London Netherton S Syndrome in Halifax Netherton S Syndrome in New York Netherton S Syndrome in Los Angeles Netherton S Syndrome in Chicago Netherton S Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease